Thyroxine-induced hyperthyroidism upon the reproductive performance of female rats

Triiodothyronine-induced hyperthyroidism and reproduction in female rats

The effect of L-triiodothyronine (L-T3)-induced hyperthyroidism on reproduction in female rats was studied. Treatment groups used were normal control, 1, 2, 4, 8, and 16 micrograms L-T3/100 g body weight (b.w.)/day. Subcutaneous injections of L-T3 began the first day of estrus until day 1 or day 19 of lactation. All rats given 1, 2, or 4 micrograms L-T3 had regular estrous cycles and normal number of pregnancies. Levels of L-T3 at 8 or 16 micrograms results in abnormal estrous cycles. Only one pregnancy occurred in the 8 micrograms group and no rats became pregnant in the 16 micrograms group. While groups on 1 or 2 micrograms L-T3 had normal parturition, groups on 4 micrograms or more showed signs of dystocia. Only the 1 microgram L-T3 group lactated to day 20, but at 67% of normal control. All levels above 1 micrograms showed loss of pups by day 2 of lactation due to lack of milk production, loss of maternal behavior, and cannibalism. Mammary gland wet and dried fat-free tissue (DFFT) weights were decreased in all treated groups except 1 microgram L-T3. The wet and DFFT weights of thyroids and uteri on days 2 or 20 of lactation were not altered by L-T3 treatment, but levels above 1 microgram increased both wet and DFFT weights of adrenal glands and ovaries. The data indicate that the no observed adverse effect level (NOAEL) of L-T3 for female rat reproduction would be below 1 microgram/100 g b.w./day. L-T3 treatment at 1 microgram/100 b.w./day or above is detrimental. These effects may be mediated through a hormonal imbalance due to the accelerated metabolic rate in reproductive tissues associated with hyperthyroidism.

Effects of tri-iodothyronine administration on the disposal of oral [1-14C]triolein, lipoprotein lipase activity and lipogenesis in the rat during lactation and on removal of the litter

The effect of tri-iodothyronine (T3) administration on the utilization of dietary [14C]lipid by the mammary gland and adipose tissue of lactating and litter-removed rats was studied. (1) After an oral load of [1-14C]triolein, the lactating rats treated with T3 (50 micrograms/100 g body wt.) over 24 h showed an increase in 14CO2 production and a decrease in the total [14C]lipid transferred through the mammary gland that was paralleled by a decrease in tissue lipoprotein lipase (LPL) activity. (2) T3 administration decreased plasma prolactin in the lactating rats. Prolactin replacement in T3-treated rats restored LPL activity in the mammary gland, but did not increase the amount of dietary [14C]lipid transferred to the milk. (3) Chronic T3 administration (4 days) to lactating rats did not affect pup growth or the lipogenic rate in the mammary gland. (4) The administration of T3 to litter-removed rats inhibited the increase of LPL activity in white adipose tissue and decreased the accumulation of dietary [14C]lipid. This decrease was accompanied by increased 14CO2 production and [14C]lipid accumulation in skeletal muscle and heart. (5) It is concluded that hyperthyroidism depresses LPL activity in mammary gland and white adipose tissue, but not in muscle. The increased accumulation of [14C]lipid in muscle and increased production of 14CO2 in lactating and in litter-removed rats treated with T3 is in part due to the decreased total LPL in mammary gland and adipose tissue respectively, which are therefore less able to compete with muscle for the available plasma triacylglycerols.